Senti Biosciences Stock Price Prediction

SNTI Stock  USD 3.49  0.28  8.72%   
The RSI of Senti Biosciences' share price is below 30 as of 16th of March 2025. This usually implies that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Senti Biosciences, making its price go up or down.

Momentum 26

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of Senti Biosciences' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Senti Biosciences, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Senti Biosciences' stock price prediction:
EPS Estimate Next Year
(9.58)
Wall Street Target Price
10
Quarterly Revenue Growth
(1.00)
Using Senti Biosciences hype-based prediction, you can estimate the value of Senti Biosciences from the perspective of Senti Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Senti Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Senti because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Senti Biosciences after-hype prediction price

    
  USD 3.23  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Senti Biosciences Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Senti Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.255.0211.60
Details
Naive
Forecast
LowNextHigh
0.073.5610.14
Details
1 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.4-2.4-2.4
Details

Senti Biosciences After-Hype Price Prediction Density Analysis

As far as predicting the price of Senti Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Senti Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Senti Biosciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Senti Biosciences Estimiated After-Hype Price Volatility

In the context of predicting Senti Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Senti Biosciences' historical news coverage. Senti Biosciences' after-hype downside and upside margins for the prediction period are 0.16 and 9.81, respectively. We have considered Senti Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.49
3.23
After-hype Price
9.81
Upside
Senti Biosciences is risky at this time. Analysis and calculation of next after-hype price of Senti Biosciences is based on 3 months time horizon.

Senti Biosciences Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Senti Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Senti Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Senti Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.40 
6.58
  0.26 
  0.03 
5 Events / Month
9 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.49
3.23
7.45 
1,012  
Notes

Senti Biosciences Hype Timeline

Senti Biosciences is at this time traded for 3.49. The entity has historical hype elasticity of -0.26, and average elasticity to hype of competition of -0.03. Senti is anticipated to decline in value after the next headline, with the price expected to drop to 3.23. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -7.45%, whereas the daily expected return is at this time at -0.4%. The volatility of related hype on Senti Biosciences is about 7902.65%, with the expected price after the next announcement by competition of 3.46. About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Senti Biosciences recorded a loss per share of 15.59. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 18th of July 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days.
Check out Senti Biosciences Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.

Senti Biosciences Related Hype Analysis

Having access to credible news sources related to Senti Biosciences' direct competition is more important than ever and may enhance your ability to predict Senti Biosciences' future price movements. Getting to know how Senti Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Senti Biosciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ZIVOZivo Bioscience 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CVKDCadrenal Therapeutics, Common(0.24)10 per month 4.55  0.16  11.59 (8.49) 25.08 
FHTXFoghorn Therapeutics 0.19 10 per month 0.00 (0.07) 9.05 (8.30) 26.22 
QNRXQuoin Pharmaceuticals Ltd 0.03 9 per month 0.00 (0.13) 14.29 (10.53) 57.78 
SABSWSAB Biotherapeutics 0.02 3 per month 18.41  0.1  50.19 (38.46) 214.55 
CINGCingulate(0.07)9 per month 0.00 (0.03) 4.82 (4.97) 24.40 
BLCMBellicum Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
HILSHillstream Biopharma 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
LIPOLipella Pharmaceuticals Common(2.00)8 per month 7.77  0.03  12.62 (10.68) 114.21 
FENCFennec Pharmaceuticals 0.14 11 per month 2.83  0.08  4.75 (3.56) 16.33 
MNPRMonopar Therapeutics 1.01 8 per month 7.58  0.11  14.92 (11.91) 38.32 
AMTIApplied Molecular Transport 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NLTXNeoleukin Therapeutics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SABSSAB Biotherapeutics(0.47)5 per month 0.00 (0.02) 13.14 (9.41) 101.06 
CNTBConnect Biopharma Holdings 0.05 5 per month 0.00 (0.03) 7.89 (7.07) 29.84 
TYRATyra Biosciences(0.26)7 per month 0.00 (0.1) 7.08 (4.81) 15.45 
RAPTRAPT Therapeutics(0.02)5 per month 4.67  0.06  9.09 (8.97) 119.01 
XLOXilio Development(0.01)7 per month 7.35  0.04  11.46 (12.84) 137.08 
MLYSMineralys Therapeutics, Common 0.05 9 per month 4.56  0.06  10.04 (8.23) 50.53 

Senti Biosciences Additional Predictive Modules

Most predictive techniques to examine Senti price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Senti using various technical indicators. When you analyze Senti charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Senti Biosciences Predictive Indicators

The successful prediction of Senti Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Senti Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Senti Biosciences based on analysis of Senti Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Senti Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Senti Biosciences's related companies.
 2022 2024 2025 (projected)
Payables Turnover2.864.828.2
Days Of Inventory On Hand306.25275.62165.99

Story Coverage note for Senti Biosciences

The number of cover stories for Senti Biosciences depends on current market conditions and Senti Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Senti Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Senti Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Senti Biosciences Short Properties

Senti Biosciences' future price predictability will typically decrease when Senti Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Senti Biosciences often depends not only on the future outlook of the potential Senti Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Senti Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.4 M
Cash And Short Term Investments35.9 M

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine